SEC 13F Intelligence

Boxer Capital, LLC / SYRE

Boxer Capital, LLC’s Spyre Therapeutics Inc Position

Does Boxer Capital, LLC own Spyre Therapeutics Inc (SYRE)? Not currently — the last reported position was 696.5K shares worth $20M in Q3 2024; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$20M
Q3 2024
Shares
696.5K
% of Portfolio
+1.01%
Quarters Held
4
position exited

Position History SYRE

Reported value by quarter
Q4 ’23: $5MQ4 ’23Q1 ’24: $9MQ1 ’24Q2 ’24: $16MQ2 ’24Q3 ’24: $20MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024696.5K$20M+1.01%
Q2 2024696.5K$16M+0.86%
Q1 2024250.0K$9M+0.47%
Q4 2023250.0K$5M+0.27%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of SYRE.